Gelone Steven P. 4
4 · Nabriva Therapeutics plc · Filed Jan 31, 2023
Insider Transaction Report
Form 4
Gelone Steven P.
Chief Development Officer
Transactions
- Tax Payment
Ordinary Shares
2023-01-29$1.50/sh−140$210→ 14,283 total
Footnotes (1)
- [F1]These ordinary shares were withheld by the Issuer in order to satisfy tax withholding obligations upon the vesting of certain restricted share units.